Immunotherapy breakthrough: Pembrolizumab extends time to recurrence in aggressive bladder cancer

  • Post author:
  • Post category:uncategorized

Patients with muscle-invasive urothelial cancer and a high risk of recurrence after surgery may have a new treatment option.